Merus N.V. (MRUS)
NASDAQ: MRUS · Real-Time Price · USD
41.83
-1.38 (-3.19%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Merus Market Cap
Merus has a market cap or net worth of $2.89 billion as of April 24, 2025. Its market cap has increased by 11.71% in one year.
Market Cap
2.89B
Enterprise Value
2.18B
1-Year Change
11.71%
Ranking
Category
Stock Price
$41.83
Market Cap Chart
Since May 19, 2016, Merus's market cap has increased from $143.00M to $2.89B, an increase of 1,921.02%. That is a compound annual growth rate of 40.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2025 | 2.99B | 3.70% |
| Dec 31, 2024 | 2.88B | 81.33% |
| Dec 29, 2023 | 1.59B | 121.65% |
| Dec 30, 2022 | 716.30M | -41.96% |
| Dec 31, 2021 | 1.23B | 142.03% |
| Dec 31, 2020 | 509.90M | 55.03% |
| Dec 31, 2019 | 328.90M | 20.92% |
| Dec 31, 2018 | 272.00M | -12.85% |
| Dec 29, 2017 | 312.10M | 3.83% |
| Dec 30, 2016 | 300.60M | 110.21% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 740.81B |
| UnitedHealth Group | 398.16B |
| Johnson & Johnson | 379.62B |
| AbbVie | 303.61B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 227.79B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |